| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Gene Are Associated with Low Levels of Gs
Protein in Growth Hormone-Secreting Tumors1
Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, Italian Auxologic Center IRCCS (A.M.D.B.), and the Department of Pharmacology, CNR Center of Cytopharmacology, Scientific Institute San Raffaele, University of Milan (L.V.), Milan, Italy
Address all correspondence and requests for reprints to: Anna Spada, M.D., Istituto di Scienze Endocrine Ospedale Maggiore, IRCCS, Via Francesco Sforza 35, 20122 Milan, Italy. E-mail: endosci{at}imiucca.csi unimi.it.
Evidence suggests the existence of a direct relationship between
cellular Gs
content and activation of the adenylyl
cyclase system. Data on Gs
levels in endocrine tumors
that depend on cAMP for growth, particularly pituitary adenomas, are
still limited. The levels of Gs
protein were evaluated
in 11 GH-secreting adenomas with Gs
mutations
(gsp+) and 15 without (gsp).
Complementary DNAs from gsp+ tumors
contained very low amounts of wild-type Gs
sequences,
indicating a preponderance of the mutant Gs
transcripts
in these tumors. Immunoblotting of Gs
protein showed
that the two isoforms were present at high levels in all
gsp-, but were undetectable or barely
detectable in gsp+. The low
Gs
content in gsp+ tumors was
not due to a reduction in ribonucleic acid synthesis or stability, as
Gs
messenger ribonucleic acid levels were similar in
wild-type and mutant tissues. Treatment of
gsp- cells with cholera toxin caused a
marked reduction of Gs
levels. As in other cell systems
cholera toxin increases Gs
degradation, our data are
consistent with an accelerated removal of mutant Gs
.
This may represent an additional mechanism of feedback response to the
constitutive activation of cAMP signaling in pituitary tumors with
mutations in the Gs
gene.
This article has been cited by other articles:
![]() |
S.-Y. Kim, M. Seo, Y. Kim, Y.-I. Lee, J.-M. Oh, E.-A. Cho, J.-S. Kang, and Y.-S. Juhnn Stimulatory Heterotrimeric GTP-binding Protein Inhibits Hydrogen Peroxide-induced Apoptosis by Repressing BAK Induction in SH-SY5Y Human Neuroblastoma Cells J. Biol. Chem., January 18, 2008; 283(3): 1350 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines Endocrinology, June 1, 2007; 148(6): 2973 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lania, G. Mantovani, and A. Spada Genetics of Pituitary Tumors: Focus on G-Protein Mutations Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lania, M. Filopanti, S. Corbetta, M. Losa, E. Ballare, P. Beck-Peccoz, and A. Spada Effects of Hypothalamic Neuropeptides on Extracellular Signal-Regulated Kinase (ERK1 and ERK2) Cascade in Human Tumoral Pituitary Cells J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1692 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mantovani, E. Ballare, E. Giammona, P. Beck-Peccoz, and A. Spada The Gs{alpha} Gene: Predominant Maternal Origin of Transcription in Human Thyroid Gland and Gonads J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4736 - 4740. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. WEINSTEIN, M. CHEN, and J. LIU Gs{alpha} Mutations and Imprinting Defects in Human Disease Ann. N.Y. Acad. Sci., June 1, 2002; 968(1): 173 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ballare, L. Persani, A. G. Lania, M. Filopanti, E. Giammona, S. Corbetta, S. Mantovani, M. Arosio, P. Beck-Peccoz, G. Faglia, et al. Mutation of Somatostatin Receptor Type 5 in an Acromegalic Patient Resistant to Somatostatin Analog Treatment J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3809 - 3814. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peri, B. Conforti, S. Baglioni-Peri, P. Luciani, F. Cioppi, L. Buci, S. Corbetta, E. Ballaré, M. Serio, and A. Spada Expression of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor Genes in Growth Hormone-Secreting Pituitary Adenomas with or without Mutations of the Gs{{alpha}} Gene J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2111 - 2117. [Abstract] [Full Text] |
||||
![]() |
G. Mantovani, R. Romoli, G. Weber, V. Brunelli, E. De Menis, S. Beccio, P. Beck-Peccoz, and A. Spada Mutational Analysis of GNAS1 in Patients with Pseudohypoparathyroidism: Identification of Two Novel Mutations J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4243 - 4248. [Abstract] [Full Text] |
||||
![]() |
A. Barlier, I. Pellegrini-Bouiller, G. Gunz, A. J. Zamora, P. Jaquet, and A. Enjalbert Impact of gsp Oncogene on the Expression of Genes Coding for Gs{alpha}, Pit-1, Gi2{alpha}, and Somatostatin Receptor 2 in Human Somatotroph Adenomas: Involvement in Octreotide Sensitivity J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2759 - 2765. [Abstract] [Full Text] |
||||
![]() |
R. Romoli, A. Lania, G. Mantovani, S. Corbetta, L. Persani, and A. Spada Expression of Calcium-Sensing Receptor and Characterization of Intracellular Signaling in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2848 - 2853. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |